Nucleosides with anti-hepatitis B virus activity

Author：  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.11, Iss.3, 2001-03, pp. : 503-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design and Development of Anti-Hepatitis B Virus Agents

By  

Current Medicinal Chemistry, Vol. 17, Iss. 29, 2010-10 ,pp. : 3377-3392

Bentham Science Publishers

Access to resources Recommend Favorite

Exploiting New Potential Targets for Anti-Hepatitis B Virus Drugs

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. : 241-246

Bentham Science Publishers

Access to resources Recommend Favorite

Sesquiterpene Lactones with Anti-Hepatitis C Virus Activity Using Molecular Descriptors

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 9, 2012-11 ,pp. : 881-890

Bentham Science Publishers

Access to resources Recommend Favorite

4’-Modified Pyrimidine Nucleosides as Potential Anti-hepatitis C Virus (HCV) Agents

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 7, 2014-08 ,pp. : 917-921

Bentham Science Publishers

Access to resources Recommend Favorite

Promising Targets for Anti-Hepatitis C Virus Agents

By  

Current Medicinal Chemistry, Vol. 18, Iss. 8, 2011-03 ,pp. : 1239-1244

Bentham Science Publishers

Access to resources Recommend Favorite